Astrana Health Q2 revenue $654.8M, +35% YoY; adjusted EBITDA $48.1M, guidance reiterated

Astrana Health, Inc.

2025-Q2 EPS reported $0.33 vs consensus $0.37 ▼ miss (-10.9%)

Total revenue $654.8M, up 35% from $486.3M; adjusted EBITDA $48.1M, both at higher end of guidance.
Net income $9.4M, EPS-diluted $0.19; six-month EPS $0.33.
Care Partners revenue $631.4M, up 36% YoY.
Reiterates full-year 2025 guidance, inclusive of completed Prospect Health acquisition.
Medical cost trends within expectations across all lines of business.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.